Xenon Pharmaceuticals director Steven Gannon disposes of 10,000 common shares for $640,550
XENE•Director sale disclosed in SEC filing
- Xenon Pharmaceuticals director Steven Gannon sold 10,000 common shares on Aug. 11, 2026 at a weighted-average price of $64.06.
- Gannon’s direct holding fell to 1,870 common shares following the sale.
